The distribution of congenital anomalies within the VACTERL association among tumor necrosis factor antagonist-exposed pregnancies is similar to the general population

Journal of Rheumatology

Volumn 38, Issue 9, 2011, Pages 1871-1874

  Crijns, Hubertina J M J ^a,d   Jentink, Janneke ^b,d   Garne, Ester ^c,d   Gispen De Wied, Christine C ^d   Straus, Sabine M J M ^d   De Jong Van Den Berg, Lolkje T W ^b,d  

^a MEDICINES EVALUATION BOARD   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c KOLDING HOSPITAL   (Denmark)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Birth defect; EUROCAT; Safety; Tumor necrosis factor antagonists; VACTERL association

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; CONGENITAL MALFORMATION; DATA BASE; EUROCAT DATABASE; HUMAN; LIMB MALFORMATION; MEDICAL RECORD; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; VACTERL ASSOCIATION; VERTEBRAL DEFECT ANAL ATRESIA CARDIAC TRACHEOESOPHAGEAL RENAL AND LIMB ABNORMALITIES;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANAL CANAL; COHORT STUDIES; DATABASES, FACTUAL; ESOPHAGUS; EUROPE; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; KIDNEY; LIMB DEFORMITIES, CONGENITAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SPINE; TRACHEA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052326092     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101316     Document Type: Article

References (14)

1. Berthelot J-M, De Brandt M, Goupille P, Solau-Gervais E, Loité F, Goed V, et al. Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature. Joint Bone Spine 2009;76:28-34.
2. Carter JD, Ladhani A, Vasey FB. Tumor necrosis factor inhibition and VATER association: a causal relationship? J Rheumatol 2006;33:1014-7.
3. Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB. A safety assessment of TNF antagonists during pregnancy: a review of the FDA database. J Rheumatol 2009;36:635-41.
4. Källén K, Mastroiacovo P, Castilla EE, Robert E, Källén B. VATER non-random association of congenital malformations: Study based on data from four malformation registers. Am J Med Genet 2001;101:23-32.
5. Barnes JC, Smith WL. The VATER association. Radiology 1978;126:445-9. (Pubitemid 8283764)
6. Botto LD, Khoury MJ, Mastroiacovo P, Castilla EE, Moore CA, Skjaerven R, et al. The spectrum of congenital anomalies of theVATER association: An international study. Am J Med Genet 1997;71:8-15.
7. US Food and Drug Administration. Adverse Event Reporting System. Silver Spring, MD. [Internet. Accessed May 11, 2011.] Available from: www.fda.gov/drugs/GuidanceComplianceRegulatoryInformation/surveillance/ adversedrugeffects
8. EUROCAT. EUROCAT Guide 1.3 and reference documents, instructions for the registration and surveillance of congenital anomalies, September 2005. [Internet. Accessed May 11, 2011.] Available from: http://www.eurocat.ulster.ac. uk/pdf/ EUROCAT-Guide
9. Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 2010;362:2185-93.
10. European Medicines Agency. London. European public assessment reports: Enbrel. [Internet. Accessed May 11, 2011.] Available from: http://www.ema. europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000262/ human-med-000764.jsp&murl=menus/medicines/medicines.jsp&mid= WC0b01ac058001d125
11. European Medicines Agency. London. European public assessment reports: Humira. [Internet. Accessed May 11, 2011.] Available from: http://www.ema. europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000481/ human-med-000822.jsp&murl=menus/medicines/medicines.jsp&mid= WC0b01ac058001d125
12. European Medicines Agency. London. European public assessment reports: Remicade. [Internet. Accessed May 11, 2011.] Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/ 000240/human-med-001023.jsp&murl=menus/medicines/medicines.jsp&mid= WC0b01ac058001d125
13. Quan L, Smith DW. The VATER assocation: Vertebral defects, anal atresia, T-E fistula with esophageal atresia, radial and renal dysplasia: A spectrum of associated defects. J Pediatr 1973;82:104-7.
14. Mitchel AA. Systematic identification of drugs that cause birth defects - a new opportunity. N Engl J Med 2003;349:2556-9.